mebendazole has been researched along with Leukemia, Myeloid, Acute in 5 studies
Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.
Leukemia, Myeloid, Acute: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Freisleben, F | 1 |
| Modemann, F | 1 |
| Muschhammer, J | 1 |
| Stamm, H | 1 |
| Brauneck, F | 1 |
| Krispien, A | 1 |
| Bokemeyer, C | 1 |
| Kirschner, KN | 1 |
| Wellbrock, J | 1 |
| Fiedler, W | 1 |
| Clesham, K | 1 |
| Walf-Vorderwülbecke, V | 2 |
| Gasparoli, L | 1 |
| Virely, C | 1 |
| Cantilena, S | 1 |
| Tsakaneli, A | 1 |
| Inglott, S | 1 |
| Adams, S | 2 |
| Samarasinghe, S | 2 |
| Bartram, J | 2 |
| Williams, G | 2 |
| de Boer, J | 2 |
| Williams, O | 2 |
| Li, Y | 1 |
| Thomas, D | 1 |
| Deutzmann, A | 1 |
| Majeti, R | 1 |
| Felsher, DW | 1 |
| Dill, DL | 1 |
| Pearce, K | 1 |
| Brooks, T | 1 |
| Hubank, M | 1 |
| van den Heuvel-Eibrink, MM | 1 |
| Zwaan, CM | 1 |
| Edwards, D | 1 |
| Ancliff, P | 1 |
| Khwaja, A | 1 |
| Goulden, N | 1 |
| He, L | 1 |
| Shi, L | 1 |
| Du, Z | 1 |
| Huang, H | 1 |
| Gong, R | 1 |
| Ma, L | 1 |
| Chen, L | 1 |
| Gao, S | 1 |
| Lyu, J | 1 |
| Gu, H | 1 |
5 other studies available for mebendazole and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Mebendazole Mediates Proteasomal Degradation of GLI Transcription Factors in Acute Myeloid Leukemia.
Topics: Case-Control Studies; Heat-Shock Proteins; Humans; Leukemia, Myeloid, Acute; Mebendazole; Proteasome | 2021 |
Identification of a c-MYB-directed therapeutic for acute myeloid leukemia.
Topics: Humans; Leukemia, Myeloid, Acute; Mebendazole; Oncogenes; Proto-Oncogene Proteins c-myb; Transcripti | 2022 |
Mebendazole for Differentiation Therapy of Acute Myeloid Leukemia Identified by a Lineage Maturation Index.
Topics: Animals; Antineoplastic Agents; Cell Differentiation; Cell Lineage; Cell Proliferation; Computationa | 2019 |
Targeting acute myeloid leukemia by drug-induced c-MYB degradation.
Topics: Animals; Child; Female; Humans; Infant; Leukemia, Myeloid, Acute; Male; Mebendazole; Mice; Oncogenes | 2018 |
Mebendazole exhibits potent anti-leukemia activity on acute myeloid leukemia.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Female; HEK293 Cell | 2018 |